z-logo
open-access-imgOpen Access
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
Author(s) -
Toussaint Rouamba,
Espérance Ouédraogo,
Houreratou Barry,
Nobila Valentin Yaméogo,
Apoline Sondo,
Rainatou Boly,
Jacques Zoungrana,
A.R. Ouédraogo,
Marc Christian Tahita,
Armel Poda,
Éric Arnaud Diendéré,
Abdoul–Salam Ouédraogo,
Innocent Valéa,
Isidore Traoré,
Zékiba Tarnagda,
Maxime Drabo,
Halidou Tinto
Publication year - 2022
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2022.02.034
Subject(s) - hydroxychloroquine , azithromycin , chloroquine , medicine , covid-19 , virology , intensive care medicine , immunology , malaria , biology , antibiotics , disease , infectious disease (medical specialty) , microbiology and biotechnology , outbreak
Our study aimed to assess the statistical relationship between the use of chloroquine phosphate or hydroxychloroquine plus azithromycin (CQ/HCQ + AZ) and virological recovery, disease worsening, and death among out- and inpatients with COVID-19 in Burkina Faso.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom